How close are we to revealing the etiology of Parkinson's disease?

Expert Review of Neurotherapeutics

Volumn 15, Issue 10, 2015, Pages 1105-1107

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

disease etiology; Lewy pathology; Parkinsons disease; pathogenic role of a synuclein; prion like spread

Indexed keywords

ALPHA SYNUCLEIN;

AUTONOMIC DYSFUNCTION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; GENE MUTATION; HUMAN; LEWY BODY; MOLECULAR PATHOLOGY; MOTOR DYSFUNCTION; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURITE; NIGRONEOSTRIATAL SYSTEM; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; ENVIRONMENT; GENETICS; METABOLISM; PATHOLOGY;

ENVIRONMENT; HUMANS; PARKINSON DISEASE;

EID: 84942987881     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1079486     Document Type: Review

References (20)

1. Jellinger KA. Neuropathology of Parkinsons disease. In: Thomas M.,. editor. Inflammation in Parkinsons Disease: Scientific and Clinical Aspects. Springer; NY, USA: 2014. p. 25-47
2. Gallegos S, Pacheco C, Peters C, et al. Features of alpha-synuclein that could explain the progression and irreversibility of Parkinsons disease. Front Neurosci 2015; 9: 59
3. Hernandez DG, Singleton AB. Genetics of Parkinsons disease. In: Brás JMT.,. editor. Movement disorder genetics Schneider. Springer; SA: 2015. p. 19-34
4. Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinsons disease. Neuron 2015; 85: 257-73
5. Gardner RC, Burke JF, Nettiksimmons J, et al. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol 2015; 77: 987-95
6. Bu XL, Wang X, Xiang Y, et al. The association between infectious burden and Parkinsons disease: A case-control study. Parkinsonism Relat Disord 2015; 21: 877-81
7. Verstraeten A, Theuns J, Van Broeckhoven C. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet 2015; 31: 140-9
8. Rodriguez M, Rodriguez-Sabate C, Morales I, et al. Parkinsons disease as a result of aging. Aging Cell 2015; 14: 293-308
9. Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 2015; 9: 124
10. Goldman SM. Environmental toxins and Parkinsons disease. Annu Rev Pharmacol Toxicol 2014; 54: 141-64
11. Eschbach J, Danzer KM. alpha-Synuclein in Parkinsons disease: pathogenic function and translation into animal models. Neurodegener Dis 2014; 14: 1-17
12. Johnson ME, Bobrovskaya L. An update on the rotenone models of Parkinsons disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 2015; 46: 101-16
13. Jellinger KA. Synuclein and parkinsons disease: an update. In: Martinez A, Gil C.,. editors. Emerging drugs and targets for parkinsons disease. The Royal Society of; Chemistry; London, UK: 2013. p. 175-214
14. Roberts RF, Wade-Martins R, Alegre-Abarrategui J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinsons disease brain. Brain 2015; 138: 1642-57
15. Riley BE, Gardai SJ, Emig-Agius D, et al. Systems-based analyses of brain regions functionally impacted in Parkinsons disease reveals underlying causal mechanisms. PLoS One 2014; 9 (8): e102909
16. Hurley MJ, Brandon B, Gentleman SM, Dexter DT. Parkinsons disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain 2013; 136: 2077-97
17. Schulz-Schaeffer WJ. Is cell death primary or secondary in the pathophysiology of idiopathic Parkinsons disease? Biomolecules 2015; 5: 1467-79
18. Kovacs GG, Breydo L, Green R, et al. Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 2014; 69: 76-92
19. Peelaerts W, Bousset L, Van der Perren A, et al. Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 2015; 522: 340-4
20. Schweighauser M, Bacioglu M, Fritschi SK, et al. Formaldehyde-fixed brain tissue from spontaneously ill alpha-synuclein transgenic mice induces fatal alpha-synucleinopathy in transgenic hosts. Acta Neuropathol 2015; 129: 157-9